Serigne Lo

15.0k citations

274 papers · 6.0k indexed · 1 hit paper · h-index 39

Oncology top 0.5%
- Cutaneous Melanoma Detection and Management 108
- Cancer Immunotherapy and Biomarkers 63
- CAR-T cell therapy research 55
Nephrology top 0.5%
Critical Care and Intensive Care Medicine top 1%
Immunology top 5%
- Immunotherapy and Immune Responses 32
Pulmonary and Respiratory Medicine top 2%
- Brain Metastases and Treatment 22
Molecular Biology
- Melanoma and MAPK Pathways 64
Epidemiology
- Nonmelanoma Skin Cancer Studies 28
Economics and Econometrics
- Health Systems, Economic Evaluations, Quality of Life 18

Co-authors: Richard A. Scolyer Georgina V. Long Alexander M. Menzies Matteo S. Carlino Alexander Guminski John F. Thompson Maria Gonzalez James S. Wilmott
Cited by: Oncology Nephrology Critical Care and Intensive Care Medicine
Journals: Journal of Clinical Oncology (35 papers)Annals of Oncology (22 papers)Annals of Surgical Oncology (16 papers)
Partner nations: Australia United States United Kingdom

In The Last Decade

Serigne Lo

251 papers receiving 5.9k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Serigne Lo

Since Specialization

Citations

This map shows the geographic impact of Serigne Lo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serigne Lo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serigne Lo more than expected).

Fields of papers citing papers by Serigne Lo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Serigne Lo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serigne Lo. The network helps show where Serigne Lo may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Serigne Lo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Serigne Lo Line = papers co-authored together Serigne Lo links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Prognostic significance of sentinel node tumor burden in Merkel Cell Carcinoma SHILAP Revista de lepidopterología ·Putu Yogiswara,M. Ben Joseph,Terence Z. Wong,Janiele Ferreira da Silva Sousa,Serigne Lo,刘海潮,Sydney Ch’ng,Angela Hong,Kerwin F. Shannon,W. Martin C. Klop,Winan J. van Houdt,Michel W.J.M. Wouters,Margot Tesselaar,Richard A. Scolyer,Alexander C. J. van Akkooi	2025	1
2	Spontaneous Coronary Artery Dissection: A Narrative Review of Epidemiology and Public Health Implications Medicina ·Vera Atiga-Anderson,Tony E. Afejuku,G.L. Prajapati,Francisco Secundo da Silva Neto,James Xu,Matthew Hollings,Serigne Lo,Kazuaki Negishi,Sarah Zaman	2025	2
3	The Prognostic Significance of Tumoral Melanosis Journal of Cutaneous Pathology ·Alison J. Potter,Peter M. Ferguson,Serigne Lo,Tasnia Ahmed,Robert V. Rawson,John F. Thompson,Georgina V. Long,Richard A. Scolyer	2024	0
4	In vivo reflectance confocal microscopy role for early to advanced lentigo maligna melanoma spectrum: A systematic review and pooled analysis Journal of the European Academy of Dermatology and Venereology ·MohammadHossein MohammadAli Khalaj,Peter M. Ferguson,Serigne Lo,Helena Collgros,Linda K. Martin,Christoph Sinz,Amelia K. Smit,Ana Lidia Coutinho dos Santos,Choudhary Zahid Javid,Mohammad Abravesh,Richard A. Scolyer,Anne Ε. Cust,Pascale Guitera	2024	1
5	FDG-PET associations with pathological response and survival with neoadjuvant immunotherapy for melanoma. Journal of Clinical Oncology ·Li Zhou,Edward Hsiao,Serigne Lo,Matteo S. Carlino,George Au‐Yeung,Maria Gonzalez,Andrew J. Spillane,Thomas E. Pennington,Julie R. Howle,Kerwin F. Shannon,Rony Kapoor,Jonathan R. Stretch,David Gyorki,Robyn P.M. Saw,Sydney Ch’ng,Richard A. Scolyer,Georgina V. Long,Alexander M. Menzies	2024	0
6	A randomised, controlled, multicentre trial of imiquimod versus radiotherapy for lentigo maligna. Journal of Clinical Oncology ·Angela Hong,Serigne Lo,Gerald B. Fogarty,Jonathan R. Stretch,Wei Wang,Pablo Fernández‐Peñas,Richard C. Martin,Matthew Foote,H. Peter Soyer,Jeremy Ruben,Victoria Mar,M. Osman Kamelia,知也村瀬,Helena Collgros,Amanda Pereira,MohammadHossein MohammadAli Khalaj,Richard A. Scolyer,Madeleine King,Pascale Guitera	2024	5
7	Neoadjuvant nivolumab plus ipilimumab versus adjuvant nivolumab in macroscopic, resectable stage III melanoma: The phase 3 NADINA trial. Journal of Clinical Oncology ·Christian U. Blank,Arjun Gaihre,Richard A. Scolyer,Bart A. van de Wiel,Alexander M. Menzies,Marta López‐Yurda,Alexander Christopher Jonathan Van Akkooi,Winan J. van Houdt,Robyn P.M. Saw,Anton Maturbongs,Serigne Lo,Geke A.P. Hospers,Matteo S. Carlino,Jan Willem de Groot,Ellen Kapiteijn,Karijn P.M. Suijkerbuijk,Piotr Rutkowski,Shahneen Sandhu,Alleva E.,Georgina V. Long	2024	9
8	Five-year analysis of neoadjuvant dabrafenib and trametinib for stage III melanoma Annals of Oncology ·Alexander M. Menzies,Serigne Lo,Robyn P.M. Saw,Maria Gonzalez,Sydney Ch’ng,Pablo Mori Bregante,Kerwin F. Shannon,Kei Yoneda,Jenny Lee,Louise Emmett,Tara Kheradyar,Shahboz Khujamov,Jonathan R. Stretch,John F. Thompson,Eduardo Rivé Lockwood,Helen Rizos,Raquel Pereira Buroxid,Georgina V. Long	2024	8
9	Cross-platform comparison of immune signatures in immunotherapy-treated patients with advanced melanoma using a rank-based scoring approach Journal of Translational Medicine ·Mojdeh Amini Faskhodi,Tuba N. Gide,Nurudeen A. Adegoke,Camelia Quek,Y.P. Konovalova,Alison J. Potter,Ellis Patrick,Robyn P.M. Saw,John F. Thompson,Andrew J. Spillane,Kerwin F. Shannon,Matteo S. Carlino,Serigne Lo,Alexander M. Menzies,Inês Pires da Silva,Georgina V. Long,Richard A. Scolyer,James S. Wilmott	2023	6
10	VEGF Inhibitors Improve Survival Outcomes in Patients with Liver Metastases across Cancer Types—A Meta-Analysis Cancers ·裕之太田,Mary E. Etzel,Serigne Lo,Richard A. Scolyer,Matteo S. Carlino,Alexander M. Menzies,Georgina V. Long,Inês Pires da Silva	2023	4
11	Time interval between diagnostic excision-biopsy of a primary melanoma and sentinel node biopsy: effects on the sentinel node positivity rate and survival outcomes European Journal of Cancer ·Omatsu,Richard A. Scolyer,Carla H. van Gils,Sydney Ch’ng,Omgo E. Nieweg,Thomas E. Pennington,Robyn P.M. Saw,Kerwin F. Shannon,Andrew J. Spillane,Jonathan R. Stretch,Arjen J. Witkamp,V. Sigurdsson,John F. Thompson,P. J. van Diest,Serigne Lo	2022	8
12	Effect of the time interval between melanoma diagnosis and sentinel node biopsy on the size of metastatic tumour deposits in node-positive patients European Journal of Cancer ·Omatsu,Richard A. Scolyer,Carla H. van Gils,Sydney Ch’ng,Omgo E. Nieweg,Thomas E. Pennington,Robyn P.M. Saw,Kerwin F. Shannon,Andrew J. Spillane,Jonathan R. Stretch,Arjen J. Witkamp,V. Sigurdsson,John F. Thompson,P. J. van Diest,Serigne Lo	2022	5
13	Histological regression in melanoma: impact on sentinel lymph node status and survival Modern Pathology ·Wen Cheng,Tasnia Ahmed,Omatsu,Jonathan R. Stretch,Robyn P.M. Saw,Andrew J. Spillane,Kerwin F. Shannon,Sydney Ch’ng,Omgo E. Nieweg,John F. Thompson,Serigne Lo,Richard A. Scolyer	2021	23
14	Field-based radiotherapy using volumetric modulated arc therapy (VMAT) for skin field cancerisation (SFC)–outcomes from 100 consecutive fields Gerald B. Fogarty,K.-D. Park,Serigne Lo,Carolina Fonseca Pereira,Susan A. Ratzan,David M. Wong,Susan Sinclair,Shaoqiu Li,Pascale Guitera,Stephen Shumack	2021	6
15	Hyperacute toxicity with combination ipilimumab and anti-PD1 immunotherapy European Journal of Cancer ·Helen Clare Dearden,Lewis Au,Daniel Wang,Lisa Zimmer,Zeynep Eroglu,Jessica L. Smith,Fanny Blanchon,Chloe Khoo,Victoria Atkinson,Serigne Lo,Georgina V. Long,Shahneen Sandhu,Paolo A. Ascierto,Matteo S. Carlino,Douglas B. Johnson,James Larkin,Alexander M. Menzies	2021	24
16	Re-defining the role of surgery in the management of patients with oligometastatic stage IV melanoma in the era of effective systemic therapies European Journal of Cancer ·Sydney Ch’ng,Semra Uyulmaz,Matteo S. Carlino,Thomas E. Pennington,Kerwin F. Shannon,ISADORA CRISTINA MOREIRA PEREIRA,Jonathan R. Stretch,Omgo E. Nieweg,Alexander H. R. Varey,Edward Hsiao,Rony Kapoor,Inês Pires da Silva,Serigne Lo,Andrew J. Spillane,Richard A. Scolyer,Georgina V. Long,Angela Hong,Robyn P.M. Saw,John F. Thompson,Alexander M. Menzies	2021	5
17	Clinical outcomes following surgical treatment of lentigo maligna of the head and neck European Journal of Surgical Oncology ·Gareth Crouch,Emma M. Nellhaus,Serigne Lo,Robyn P.M. Saw,KK Lee,Jonathan R. Stretch,Kerwin F. Shannon,Pascale Guitera,Richard A. Scolyer,John F. Thompson,Sydney Ch’ng	2020	9
18	Dynamic Changes in PD-L1 Expression and Immune Infiltrates Early During Treatment Predict Response to PD-1 Blockade in Melanoma Clinical Cancer Research ·Ricardo E. Vilain,Alexander M. Menzies,James S. Wilmott,Hojabr Kakavand,Jason Madore,Alexander Guminski,Elizabeth Liniker,Benjamin Y. Kong,Adam Cooper,Julie R. Howle,Robyn P.M. Saw,Valerie Jakrot,Serigne Lo,John F. Thompson,Matteo S. Carlino,Richard Kefford,Georgina V. Long,Richard A. Scolyer	2017	191
19	Accurate p‐values for adaptive designs with binary endpoints Statistics in Medicine ·Stéphane Héritier,Chris J. Lloyd,Serigne Lo	2017	5
20	Trends in fall-related ambulance use and hospitalisation among older adults in NSW, 2006–2013: a retrospective, population-based study Public Health Research & Practice ·Serene S. Paul,Lara Harvey,Rui Felix,Qiang Li,Soufiane Boufous,Jung-Goon Koh,Anne Tiedemann,Lindy Clemson,Stephen R. Lord,Sandy Muecke,Jacqueline Close,Serigne Lo,Catherine Sherrington	2017	14

About Serigne Lo

Serigne Lo is a scholar working on Oncology, Nephrology, Biophysics, Statistics and Probability and Immunology, having authored 274 papers that have together received 6.0k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (108 papers), Melanoma and MAPK Pathways (64 papers), Cancer Immunotherapy and Biomarkers (63 papers), CAR-T cell therapy research (55 papers), Immunotherapy and Immune Responses (32 papers), Nonmelanoma Skin Cancer Studies (28 papers), Brain Metastases and Treatment (22 papers) and Health Systems, Economic Evaluations, Quality of Life (18 papers). The work is most often cited by research in Oncology (3.2k citations), Nephrology (694 citations), Critical Care and Intensive Care Medicine (301 citations), Immunology (897 citations) and Pulmonary and Respiratory Medicine (1.3k citations). Serigne Lo has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Richard A. Scolyer, Georgina V. Long, Alexander M. Menzies, Matteo S. Carlino, Alexander Guminski, John F. Thompson, Maria Gonzalez, James S. Wilmott, Shahneen Sandhu and Grant A. McArthur. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Annals of Surgical Oncology, European Journal of Cancer and British Journal of Dermatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact